Form 4: Opus Genetics Director Acquires Shares in Lieu of Cash Compensation

Opus Genetics director James S.J. Manuso acquired 50,222 shares of common stock in lieu of cash compensation for board services.

Summary

• Director James S.J. Manuso acquired 50,222 shares of Opus Genetics common stock on January 2, 2025.
• These shares were granted in lieu of cash compensation for board services for the year 2025.
• The number of shares was calculated by dividing the total retainer for board services by the average fair market value of a share on the grant date.
• The average fair market value was determined to be $1.23 per share, based on the average of the high and low price on the grant date.
• Following this transaction, Mr. Manuso beneficially owns 182,259 shares of Opus Genetics common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally neutral to positive. The use of stock instead of cash is a positive sign for cash management.

Positives

• The grant of shares aligns the director's interests with those of the shareholders.
• Using shares instead of cash for compensation can help preserve the company's cash reserves.

Industry Context

This type of stock-based compensation is common practice for board members in many companies, particularly in the biotech sector, to align their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock-based compensation for board members is a common practice across various industries, especially in early-stage companies where cash flow may be limited.
• Many biotech companies use a combination of cash and stock options or grants to compensate their board members, aligning their interests with the company's long-term performance.
• The valuation of $1.23 per share is specific to Opus Genetics and would need to be compared to other similar companies in the gene therapy space to assess its relative value.

Stakeholder Impact

• Shareholders may view the stock grant as a positive sign of alignment between management and ownership.
• The use of stock instead of cash for compensation can be seen as a positive for the company's financial health.

Key Dates

Keywords

Opus Genetics, Director, Share Acquisition, Stock Compensation, Form 4, James S.J. Manuso, Board Services